Zaporowska-Stachowiak I, Gluszek J, Chodera A
Department of Pharmacology, Academy of Medicine, Poznań, Poland.
J Hum Hypertens. 1997 Dec;11(12):795-800. doi: 10.1038/sj.jhh.1000552.
To evaluate whether a relationship exists between insulinaemia (increased in essential hypertension) and endothelin level, we determined insulin and endothelin-1-like (ET-1-Li) immunoreactivity in blood serum by radioimmunoassay (RIA) in essential (EH, n = 64) and renovascular (RVH, n = 36) patients with hypertension and in healthy subjects (controls, n = 44). The trials were carried out in fasting patients and after an oral glucose tolerance test (OGTT, 75 g). Each group of subjects had similar body mass index (BMI) values. The mean values of insulin level were significantly (P < 0.0001 in every case) elevated in patients with essential hypertension compared with renovascular and control subjects during the whole OGTT. There was no significant difference in insulin level between subjects with renovascular hypertension and controls. ET-1-Li immunoreactivity levels were significantly increased (P < 0.005 fasting; P < 0.01 after 1 and 2 h) throughout the whole test in the essential hypertensive group compared with controls; in renovascular hypertensive patients 2 h after glucose administration the analogous difference was not statistically significant (P < 0.05 fasting; P < 0.01 after 1 h). In all the investigated groups the mean value of ET-1-Li immunoreactivity increased and decreased in parallel to the changes in insulin concentration during the OGTT. The ET-1-Li level was positively correlated with insulin concentration with a statistical significance for patients with essential hypertension 1 h after load (r = 0.6578, P < 0.05). The border of the significance level correlation was obtained in essential hypertensive patients 2 h after load (r = 0.5227, P = 0.06) and in controls 1 h after glucose administration (r = 0.5465, P = 0.054). Our results indicate a mutual connection between insulinaemia and an endothelin set; their relevance for the pathogenesis of hypertension requires further research.
为了评估胰岛素血症(原发性高血压中升高)与内皮素水平之间是否存在关联,我们通过放射免疫分析法(RIA)测定了原发性高血压患者(EH,n = 64)、肾血管性高血压患者(RVH,n = 36)以及健康受试者(对照组,n = 44)血清中的胰岛素和内皮素-1样(ET-1-Li)免疫反应性。试验在空腹患者以及口服葡萄糖耐量试验(OGTT,75 g)后进行。每组受试者的体重指数(BMI)值相似。在整个OGTT期间,原发性高血压患者的胰岛素水平平均值与肾血管性高血压患者和对照组相比显著升高(每种情况P < 0.0001)。肾血管性高血压患者与对照组之间的胰岛素水平无显著差异。与对照组相比,原发性高血压组在整个试验过程中ET-1-Li免疫反应性水平显著升高(空腹时P < 0.005;1小时和2小时后P < 0.01);在肾血管性高血压患者中,葡萄糖给药后2小时类似差异无统计学意义(空腹时P < 0.05;1小时后P < 0.01)。在所有研究组中,OGTT期间ET-1-Li免疫反应性的平均值与胰岛素浓度的变化平行升高和降低。负荷后1小时,原发性高血压患者的ET-1-Li水平与胰岛素浓度呈正相关,具有统计学意义(r = 0.6578,P < 0.05)。负荷后2小时原发性高血压患者以及葡萄糖给药后1小时对照组获得了显著性水平相关性边界(r = 0.5227,P = 0.06;r = 0.5465,P = 0.054)。我们的结果表明胰岛素血症与内皮素之间存在相互联系;它们在高血压发病机制中的相关性需要进一步研究。